The Myositis

被引:0
作者
Tomaras, Stylianos [1 ,2 ]
Feist, Eugen [1 ]
机构
[1] Helios Fachklin Rheumatol Vogelsang Gommern, Vogelsang Gommern, Germany
[2] Helios Fachklin Rheumatol Vogelsang Gommern, Sophie von Boetticher Str 1, D-39245 Vogelsang Gommern, Germany
来源
INNERE MEDIZIN | 2023年
关键词
Dermatomyositis; Antisynthetase syndrome; Muscle weakness; Myositis; inclusion body; classification; DERMATOMYOSITIS;
D O I
10.1007/s00108-023-01470-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extensive research work in the field of inflammatory myopathies over the past years has given us new insights into the classification and treatment of myositis. The myositis drug pipeline has never been stronger, although it is too early to know which products will eventually reach the market. Furthermore, in our review we try to summarize the latest German guidelines and recommendations on myositis that were recently published in June 2022. After reading this article, you should be able to describe practical considerations regarding the diagnosis, classification, and management of inflammatory myopathies. Additionally, you will be able to recognize myositis subgroups with a poor prognosis.
引用
收藏
页码:152 / 163
页数:12
相关论文
共 21 条
  • [1] Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis ("ProDERM Study")
    Aggarwal, Rohit
    Charles-Schoeman, Christina
    Schessl, Joachim
    Dimachkie, Mazen M.
    Beckmann, Irene
    Levine, Todd
    [J]. MEDICINE, 2021, 100 (01) : E23677
  • [2] Immune-mediated necrotizing myopathy: clinical features and pathogenesis
    Allenbach, Yves
    Benveniste, Olivier
    Stenzel, Werner
    Boyer, Olivier
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (12) : 689 - 701
  • [3] Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial
    Benveniste, Olivier
    Hogrel, Jean-Yves
    Belin, Lisa
    Annoussamy, Melanie
    Bachasson, Damien
    Rigolet, Aude
    Laforet, Pascal
    Dzangue-Tchoupou, Gaelle
    Salem, Joe-Elie
    Nguyen, Lee S.
    Stojkovic, Tanya
    Zahr, Noel
    Hervier, Baptiste
    Landon-Cardinal, Oceane
    Behin, Anthony
    Guilloux, Edith
    Reyngoudt, Harmen
    Amelin, Damien
    Uruha, Akinori
    Mariampillai, Kuberaka
    Marty, Benjamin
    Eymard, Bruno
    Hulot, Jean-Sebastien
    Greenberg, Steven A.
    Carlier, Pierre G.
    Allenbach, Yves
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (01) : E40 - E48
  • [4] Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group
    Cavagna, Lorenzo
    Nuno, Laura
    Scire, Carlo Alberto
    Govoni, Marcello
    Lopez Longo, Francisco Javier
    Franceschini, Franco
    Neri, Rossella
    Castaneda, Santos
    Sifuentes Giraldo, Walter Alberto
    Caporali, Roberto
    Iannone, Florenzo
    Fusaro, Enrico
    Paolazzi, Giuseppe
    Pellerito, Raffaele
    Schwarting, Andreas
    Saketkoo, Lesley Ann
    Ortego-Centeno, Norberto
    Quartuccio, Luca
    Bartoloni, Elena
    Specker, Christof
    Pina Murcia, Trinitario
    La Corte, Renato
    Furini, Federica
    Foschi, Valentina
    Bachiller Corral, Javier
    Airo, Paolo
    Cavazzana, Ilaria
    Martinez-Barrio, Julia
    Hinojosa, Michelle
    Giannini, Margherita
    Barsotti, Simone
    Menke, Julia
    Triantafyllias, Kostantinos
    Vitetta, Rosetta
    Russo, Alessandra
    Bogliolo, Laura
    Bajocchi, Gianluigi
    Bravi, Elena
    Barausse, Giovanni
    Bortolotti, Roberto
    Selmi, Carlo
    Parisi, Simone
    Salaffi, Fausto
    Montecucco, Carlomaurizio
    Angel Gonzalez-Gay, Miguel
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2017, 52 (01) : 71 - 80
  • [5] Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study
    Day, Jessica
    Otto, Sophia
    Cash, Kathy
    Limaye, Vidya
    [J]. NEUROMUSCULAR DISORDERS, 2020, 30 (03) : 186 - 199
  • [6] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Walsh, S. L. F.
    Inoue, Y.
    Richeldi, L.
    Kolb, M.
    Tetzlaff, K.
    Stowasser, S.
    Coeck, C.
    Clerisme-Beaty, E.
    Rosenstock, B.
    Quaresma, M.
    Haeufel, T.
    Goeldner, R-G
    Schlenker-Herceg, R.
    Brown, K. K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18) : 1718 - 1727
  • [7] Recent advances in dermatomyositis-specific autoantibodies
    Fujimoto, Manabu
    Watanabe, Rei
    Ishitsuka, Yosuke
    Okiyama, Naoko
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (06) : 636 - 644
  • [8] Diagnostics and treatment of statin-associated muscle symptoms
    Kassner, Ursula
    Grunwald, Stefanie
    Spira, Dominik
    Buchmann, Nikolaus
    Bobbert, Thomas
    Gazzerro, Elisabetta
    Hollstein, Tim
    Spuler, Simone
    Steinhagen-Thiessen, Elisabeth
    [J]. INTERNIST, 2021, 62 (08): : 827 - 840
  • [9] The EuroMyositis registry: an international collaborative tool to facilitate myositis research
    Lilleker, James B.
    Vencovsky, Jiri
    Wang, Guochun
    Wedderburn, Lucy R.
    Diederichsen, Louise Pyndt
    Schmidt, Jens
    Oakley, Paula
    Benveniste, Olivier
    Danieli, Maria Giovanna
    Danko, Katalin
    Nguyen Thi Phuong Thuy
    Vazquez-Del Mercado, Monica
    Andersson, Helena
    De Paepe, Boel
    debleecker, Jan L.
    Maurer, Britta
    McCann, Liza J.
    Pipitone, Nicolo
    McHugh, Neil
    Betteridge, Zoe E.
    New, Paul
    Cooper, Robert G.
    Ollier, William E.
    Lamb, Janine A.
    Krogh, Niels Steen
    Lundberg, Ingrid E.
    Chinoy, Hector
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (01) : 30 - 39
  • [10] Evaluation and construction of diagnostic criteria for inclusion body myositis
    Lloyd, Thomas E.
    Mammen, Andrew L.
    Amato, Anthony A.
    Weiss, Michael D.
    Needham, Merrilee
    Greenberg, Steven A.
    [J]. NEUROLOGY, 2014, 83 (05) : 426 - 433